Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.
Information on HIV and hepatitis C transmission and prevention, including STIs and safer sex, harm reduction, pregnancy and infant feeding, and microbicides and vaccines.
Information on diagnostic tests for HIV, hepatitis C and STIs; the delivery of testing and counselling; and resources for people who are newly diagnosed.
Information on treatment, care and support for HIV, hepatitis C and STIs, including medications, healthy living, pregnancy and infant feeding, hepatitis C re-infection, and long-term health issues.
CATIE’s online educational courses, webinars, online and print publications, and other websites.
CATIE strengthens Canada’s response to HIV and hepatitis C by bridging research and practice. We connect healthcare and community-based service providers with the latest science, and promote good practices for prevention and treatment programs.
The aim of this report is to describe new psychoactive substances which emerged in Canada since 2020.
